Renal biomarkers of kidney injury in cardiorenal syndrome

Current Heart Failure Reports

Volumn 8, Issue 2, 2011, Pages 99-105

  Comnick, Mark ^a   Ishani, Areef ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b VA MEDICAL CENTER   (United States)

Author keywords

Acute kidney injury; Albuminuria; Cardiorenal syndrome; Cystatin C; Epidemiology; Heart failure; Kidney injury molecule 1; N Acetyl D Glucosaminidase; Neutrophil gelatinase associated lipocalin; NGAL

Indexed keywords

ALBUMIN; CYSTATIN C; INTERLEUKIN 18; KIDNEY INJURY MOLECULE 1; N ACETYL BETA GLUCOSAMINIDASE; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN;

ALBUMINURIA; ARTICLE; CARDIORENAL SYNDROME TYPE 1; CONGESTIVE HEART FAILURE; HEART FAILURE; HUMAN; KIDNEY INJURY;

ACETYLGLUCOSAMINIDASE; ACUTE KIDNEY INJURY; ACUTE-PHASE PROTEINS; BIOLOGICAL MARKERS; CYSTATIN C; HEART FAILURE; HUMANS; INTERLEUKIN-18; LIPOCALINS; MEMBRANE GLYCOPROTEINS; PROTO-ONCOGENE PROTEINS; RECEPTORS, VIRUS; SYNDROME;

EID: 79957478334     PISSN: 15469530     EISSN: 15469549     Source Type: Journal    
DOI: 10.1007/s11897-011-0052-x     Document Type: Article

References (59)

1. VL Roger AS Go DM Lloyd-Jones, et al. 2010 Heart disease and stroke statistics-2010 update: a report from the American Heart Association Circulation 121 e46 214 20019324 10.1161/CIRCULATIONAHA.109.897249
2. C Ronco P McCullough SD Anker, et al. 2010 Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative Eur Heart J 31 703 11 20037146 This is a detailed description of the five types of cardiorenal syndromes
3. M Sarraf A Masoumi R Schrier 2009 Cardiorenal syndrome in acute decompensated heart failure CJASN 4 2013 26 19965544 1:CAS:528: DC%2BC3cXmt1GhtQ%3D%3D This is a thorough, in-depth review of the proposed pathophysiology involved in cardiorenal syndromes
4. P Stenvinkel JJ Carrero J Axelson, et al. 2008 Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle? CJASN 3 505 21 18184879 1:CAS:528: DC%2BD1cXhtVWlt73F This is an excellent discussion of systemic effects in chronic kidney disease and their contribution to morbidity and mortality
5. SS Gottlieb W Abraham J Butler, et al. 2002 The prognostic importance of different definitions of worsening renal function in congestive heart failure J Card Failure 8 136 41 10.1054/jcaf.2002.125289 (Pubitemid 34857278)
6. K Damman VM Deursen G Navis, et al. 2009 Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease J Am Coll Cardiol 53 582 8 19215832 10.1016/j.jacc.2008.08.080
7. Damman K, Voors AA, Hillege HL, et al. Congestion in chronic systolic heart failure is related to renal dysfunction and increased mortality. Eur J of Heart Fail 2010;1-9.
8. A Nohria V Hasselblad A Stebbens, et al. 2008 Cardiorenal interactions insights from the ESCAPE trial J Am Coll Cardiol 51 1268 74 18371557 10.1016/j.jacc.2007.08.072 (Pubitemid 351400890)
9. W Mullens Z Abrahams GS Francis, et al. 2009 Importance of venous congestion for worsening of renal function in advanced decompensated heart failure J Am Coll Cardiol 53 589 96 19215833 10.1016/j.jacc.2008.05.068
10. EL Knight RJ Glynn KM McIntyre, et al. 1999 Predictors of decreased renal function in patients with heart failure during angiotensin-converting enzyme inhibitor therapy: results from the studies of left ventricular dysfunction (SOLVD) Am Heart J 138 849 55 10539815 10.1016/S0002-8703(99)70009-8 1:STN:280:DC%2BD3c%2FgslGnsw%3D%3D (Pubitemid 29523271)
11. MR Cowie M Komajda T Murray-Thomas, et al. 2006 Prevalence and impact of worsening renal function in patients hospitalized with decompensated heart failure: results of the prospective outcomes study in heart failure (POSH) Eur Heart J 27 1216 22 16624834 10.1093/eurheartj/ehi859
12. K Damman G Navis TDJ Smilde, et al. 2007 Decreased cardiac output, venous congestion and the association with renal impairment in patients with cardiac dysfunction Eur J of Heart Fail 9 872 8 10.1016/j.ejheart.2007.05.010 (Pubitemid 47332311)
13. AV Perez K Otawa AV Zimmermann, et al. 2010 The impact of impaired renal function on mortality in patients with acutely decompensated chronic heart failure Eur J of Heart Failure 12 122 8 10.1093/eurjhf/hfp184
14. W Mullens Z Abrahams HN Skouri, et al. 2008 Elevated intra-abdominal pressure in acute decompensated heart failure J Am Coll Cardiol 51 300 6 18206740 10.1016/j.jacc.2007.09.043
15. W Mullens Z Abrahams GS Francis, et al. 2008 Prompt reduction in intra-abdominal pressure following large-volume mechanical fluid removal improves renal insufficiency in refractory decompensated heart failure J of Card Fail 14 508 14 10.1016/j.cardfail.2008.02.010 (Pubitemid 352040863)
16. MR Constanza MT Saltzberg M Jessup, et al. 2010 Ultrafiltration is associated with fewer hospitalizations than continuous diuretic infusion in patients with decompensated heart failure: results from UNLOAD J of Card Fail 16 277 84 10.1016/j.cardfail.2009.12.009
17. DE Forman J Butler Y Wang, et al. 2004 Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure JACC 43 61 7 14715185 (Pubitemid 38045917)
18. M Metra S Nodari G Parrinello, et al. 2008 Worsening renal function in patients hospitalized for acute heart failure: clinical implications and prognostic significance Eur J of Heart Fail 10 188 95 10.1016/j.ejheart.2008.01. 011 (Pubitemid 351221392)
19. GL Smith JH Lichtman MB Bracken, et al. 2006 Renal Impairment and outcomes in heart failure J Am Coll Cardiol 47 1987 96 16697315 10.1016/j.jacc.2005.11.084
20. K Damman T Jaarsma AA Voors, et al. 2009 Both in- and out-hospital worsening of renal function predict outcome in patients with heart failure: results from the Coordinating Study Evaluating Outcome of Advising and Counseling in Heart Failure (COACH) Eur J of Heart Fail 11 847 54 10.1093/eurjhf/hfp108
21. DM Cruz CY Goh A Haase-Fielitz, et al. 2010 Early biomarkers of renal injury Congest Heart Fail 16 S25 31 20653708 10.1111/j.1751-7133.2010.00163.x 1:CAS:528:DC%2BC3cXhtFGnur%2FF
22. M Lainscak MS Anker S Haehling, et al. 2009 Biomarkers for chronic heart failure Herz 34 589 93 20024637 10.1007/s00059-009-3316-4
23. HL Hillege WMT Janssen AAA Bak, et al. 2001 Microalbuminuria is common, also in a nondiabetic, nonhypertensive population, and an independent indicator of cardiovascular risk factors and cardiovascular morbidity J Intern Med 249 519 26 11422658 10.1046/j.1365-2796.2001.00833.x 1:STN:280:DC%2BD3Mznt1artg%3D%3D (Pubitemid 32823860)
24. F Bonnet M Marre JM Halimi, et al. 2006 Waist circumference and the metabolic syndrome predict the development of elevated albuminuria in non-diabetic subjects: the DESIR Study J of Hypertension 24 1157 63 10.1097/01.hjh.0000226206.03560.ac 1:CAS:528:DC%2BD28Xktlartb4%3D (Pubitemid 43772324)
25. HL Hillege V Fidler GF Diercks, et al. 2002 Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population Circulation 106 1777 82 12356629 10.1161/01.CIR.0000031732.78052.81 1:CAS:528:DC%2BD38Xnt1GnsLg%3D
26. K Klausen K Borch-Johnsen B Feldt-Rasmussen, et al. 2004 Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes Circulation 110 32 5 15210602 10.1161/01.CIR.0000133312.96477.48 1:CAS:528:DC%2BD2cXlt1Slu7Y%3D (Pubitemid 38880131)
27. HC Gerstein JFE Mann Q Yi, et al. 2001 Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals JAMA 286 421 6 11466120 10.1001/jama.286.4.421 1:CAS:528: DC%2BD3MXlvFKksL0%3D (Pubitemid 32681484)
28. T Reffelmann M Dorr H Volzke, et al. 2010 Urinary albumin excretion, even within the normal range, predicts an increase in left ventricular mass over the follow 5 years Kidney Int 77 1115 22 20200499 10.1038/ki.2010.8 1:CAS:528:DC%2BC3cXmsF2isrY%3D
29. E Ingelsson J Sundstrom L Lind, et al. 2007 Low-grade albuminuria and the incidence of heart failure in a community-based cohort of elderly men Eur Heart J 28 1739 45 17495987 10.1093/eurheartj/ehm130 1:CAS:528:DC%2BD2sXpvVKiurk%3D (Pubitemid 47227087)
30. CE Jackson SD Soloman HC Gerstein, et al. 2009 Albuminura in chronic heart failure: prevalence and prognostic importance Lancet 374 543 50 19683640 10.1016/S0140-6736(09)61378-7 1:CAS:528:DC%2BD1MXpvFygurg%3D This is an interesting analysis of the morbidity and mortality of albuminuria from the CHARM (Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity) trial
31. S Masson VM Latini L Moretti, et al. 2010 Prevalence and prognostic value of elevated urinary albumin excretion in patients with chronic heart failure Circulation Heart Failure 3 65 72 19850697 10.1161/CIRCHEARTFAILURE.109.881805 1:CAS:528:DC%2BC3cXktVSqsQ%3D%3D This is a second interesting analysis of the morbidity and mortality of albuminuria from the GISSI (Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico [Italian group for the study of the survival of myocardial infarction]) trial
32. IS Anand K Bishu TS Rector, et al. 2009 Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure Circulation 120 1577 84 19805651 10.1161/CIRCULATIONAHA.109.853648 1:CAS:528:DC%2BD1MXht1OrtrrN
33. D Bolignano G Coppolino A Romeo, et al. 2009 Neutrophil gelatinase-associated lipocalin (NGAL) reflects iron status in haemodialysis patients Nephrol Dial Transplant 24 3398 403 19549696 10.1093/ndt/gfp310 1:CAS:528:DC%2BD1MXhtlSgsrrI
34. J Malysko V Tesar IC Macdougall 2010 Neutrophil gelatinase-associated lipocalin and hepcidin: what do they have in common and is there a potential interaction? Kidney Blood Press Res 33 157 65 10.1159/000315436
35. A Friedl SP Stoesz P Buckley, et al. 1999 Neutrophil gelatinase associated lipocalin in normal and neoplastic human tissues. Cell type-specific pattern of expression Histochem J 31 433 41 10475571 10.1023/A:1003708808934 1:CAS:528:DyaK1MXlvFWjs7s%3D (Pubitemid 29369301)
36. E Meijer WE Boertien FL Nauta, et al. 2010 Association of urinary biomarkers with disease severity in patients with autosomal dominant polycystic kidney disease: a cross-sectional analysis Am J Kid Dis 56 883 95 20888104 10.1053/j.ajkd.2010.06.023 1:CAS:528:DC%2BC3cXhtlCgsbbL
37. H Ding Y He K Li, et al. 2007 Urinary neutrophil gelatinase-associated lipocalin (NGAL) is an early biomarker for renal tubulointerstitial injury in IgA nephropathy Clin Immunol 123 227 34 17360238 10.1016/j.clim.2007.01.010 1:CAS:528:DC%2BD2sXksV2ls7k%3D (Pubitemid 46613869)
38. N Paragas TL Nickolas C Wyatt, et al. 2009 Urinary NGAL marks cystic disease in HIV-associated nephropathy JASN 20 1687 92 19628667 1:CAS:528:DC%2BD1MXhtVers73J
39. A Yilmaz E Sevketoglu A Gedikbasi, et al. 2009 Early prediction of urinary tract infection with urinary neutrophil gelatinase associated lipocalin Pediatr Nephrol 24 2387 92 19649660 10.1007/s00467-009-1279-6
40. SM Bagshaw M Bennett M Haase, et al. 2010 Plasma and urine neutrophil gelatinase-associated lipocalin in septic versus non-septic acute kidney injury in critical illness Intensive Care Med 36 452 61 19956924 10.1007/s00134-009- 1724-9 1:CAS:528:DC%2BC3cXhslKksLk%3D
41. M Bennett CL Dent Q Ma, et al. 2008 Urine NGAL predicts severity of acute kidney injury after cardiac surgery: a prospective study CJASN 3 665 74 18337554
42. J Mishra C Dent R Tarabishi, et al. 2005 Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery Lancet 365 1231 8 15811456 10.1016/S0140-6736(05)74811-X 1:CAS:528: DC%2BD2MXjtlWjsLg%3D (Pubitemid 40469655)
43. SM Tuladhar VO Puntmann M Soni, et al. 2009 Rapid detection of acute kidney injury by plasma and urinary neutrophil gelatinase-associated lipocalin after cardiopulmonary bypass J Cardiovasc Pharmacol 53 261 6 19247188 10.1097/FJC.0b013e31819d6139 1:CAS:528:DC%2BD1MXjtlOhu7c%3D
44. W Han G Wagener Y Zhu, et al. 2009 Urinary biomarkers in the early detection of acute kidney injury after cardiac surgery CJASN 4 873 82 19406962 1:CAS:528:DC%2BD1MXmt1Kjs74%3D
45. C Xin X Yulong C Yu, et al. 2008 Urine neutrophil gelatinase-associated lipocalin and interleukin-18 predict acute kidney injury after cardiac surgery Ren Fail 30 904 13 18925531 10.1080/08860220802359089
46. Heise D, Rentsch K, Braeuer A, et al. Comparison of urinary neutrophil glucosaminidase-associated lipocalin, cystatin-C, and α1-microglobulin for early detection of acute renal injury after cardiac surgery. European J of Cardio-Thoracic Surgery 2010; in press.
47. K Damman DJ Veldhuisen G Navis, et al. 2008 Urinary neutrophil gelatinase associated lipocalin (NGAL), a marker of tubular damage, is increased in patients with chronic heart failure European J of Heart Failure 10 997 1000 10.1016/j.ejheart.2008.07.001 1:CAS:528:DC%2BD1cXht1eit7rM
48. K Damman DJ Veldhuisen G Navis, et al. 2010 Tubular damage is chronic systolic heart failure is associated with reduced survival independent of glomerular filtration rate Heart 96 1297 302 20659949 10.1136/hrt.2010.194878 1:CAS:528:DC%2BC3cXhtFSktrnK
49. A Aghel K Shrestha W Mullens, et al. 2010 Serum neutrophil gelatinase-associated lipocalin (NGAL) in predicting worsening renal function in acute decompensated heart failure J of Cardiac Failure 16 49 54 10.1016/j.cardfail.2009.07.003 1:CAS:528:DC%2BC3cXosFei
50. JV Bonventre L Yang 2010 Kidney injury molecule-1 Curr Opin Crit Care 16 1 6 10.1097/MCC.0b013e32834008d3
51. WK Han A Alinani CL Wu, et al. 2005 Human kidney injury molecule-1 is a tissue and urinary tumor marker of renal cell carcinoma JASN 16 1126 34 15744000 1:CAS:528:DC%2BD2MXjsVWqt7o%3D (Pubitemid 41710324)
52. O Liangos MC Perianayagam VS Vaidya, et al. 2007 Urinary N-acetyl-β-(D)-glucosaminidase activity and kidney injury molecule-1 are associated with adverse outcomes in acute renal failure JASN 18 904 12 17267747 1:CAS:528:DC%2BD2sXjs1GrsLg%3D (Pubitemid 46434507)
53. CR Parikh A Jani VY Melnikov, et al. 2004 Urinary interleukin-18 is a marker of human acute tubular necrosis Am J Kidney Dis 43 405 11 14981598 10.1053/j.ajkd.2003.10.040 1:CAS:528:DC%2BD2cXislaqsrg%3D (Pubitemid 38298199)
54. CR Parikh J Mishra H Theissen-Philbrook, et al. 2006 Urinary IL-18 is an early predictive biomarker of acute kidney injury after cardiac surgery Kidney Int 70 199 203 16710348 10.1038/sj.ki.5001527 1:CAS:528:DC%2BD28XmtlGlt7c%3D (Pubitemid 44000139)
55. M Haase R Bellomo D Story, et al. 2008 Urinary interleukin-18 does not predict acute kidney injury after adult cardiac surgery: a prospective observational cohort study Crit Care 12 1 8 10.1186/cc6972
56. CR Parikh E Abraham M Ancukiewicz, et al. 2005 Urine IL-18 is an early diagnostic marker for acute kidney injury and predicts mortality in the intensive care unit JASN 16 3046 52 16148039 1:CAS:528:DC%2BD2MXhtFegtLbM (Pubitemid 44743502)
57. M Fricker P Wiesli M Brandle, et al. 2003 Impact of thyroid dysfunction on serum cystatin C Kidney Int 63 1944 7 12675875 10.1046/j.1523-1755.2003. 00925.x 1:CAS:528:DC%2BD3sXjslygsbY%3D (Pubitemid 36513345)
58. JL Koyner MR Bennett EM Worcester, et al. 2008 Urinary cystatin C as an early biomarker of acute kidney injury following adult cardiothoracic surgery Kidney Int 74 1059 69 18650797 10.1038/ki.2008.341 1:CAS:528:DC%2BD1cXhtFyqtbfN
59. M Nejat JW Pickering RJ Walker, et al. 2010 Urinary cystatin C is diagnostic of acute kidney injury and sepsis, and predicts mortality in the intensive care unit Crit Care 14 1 1 10.1186/cc9014